Krishnan Krish S's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Jul 16, 2025
- Accession no.
- 0001298709-25-000009
- Filed
- Jul 16, 2025
- Trade date
- Jul 14-16, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions. Open-market sales total $5.39M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krishnan Krish SCIK 0001298709 | Director, Officer (President and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2025 | Common Stock | SSaleDisposed | −13,400 | $150.30F2 | −$2,014,020 | 1,512,529 | Direct | |
| Jul 15, 2025 | Common Stock | SSaleDisposed | −2,184 | $150.68F3 | −$329,085.12 | 1,510,345 | Direct | |
| Jul 15, 2025 | Common Stock | SSaleDisposed | −900 | $151.79F4 | −$136,611 | 1,509,445 | Direct | |
| Jul 16, 2025 | Common Stock | SSaleDisposed | −1,389 | $150.00F4 | −$208,350 | 1,508,056 | Direct | |
| Jul 14, 2025 | Common Stock | SSaleDisposed | −13,335 | $150.29F7 | −$2,004,117.15 | 1,443,376 | Indirect | |
| Jul 14, 2025 | Common Stock | SSaleDisposed | −100 | $151.00F4 | −$15,100 | 1,443,276 | Indirect | |
| Jul 15, 2025 | Common Stock | SSaleDisposed | −2,236 | $150.68F9 | −$336,920.48 | 1,441,040 | Indirect | |
| Jul 15, 2025 | Common Stock | SSaleDisposed | −800 | $151.79F4 | −$121,432 | 1,440,240 | Indirect | |
| Jul 16, 2025 | Common Stock | SSaleDisposed | −1,529 | $150.00F4 | −$229,350 | 1,438,711 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades ranging from $150.00 to $150.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F3
The transaction was executed in multiple trades ranging from $150.21 to $151.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F4
The transaction was executed in one trade.
Referenced by the price of 5 transactions in Table I.
- F7
The transaction was executed in multiple trades ranging from $150.00 to $150.97. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F9
The transaction was executed in multiple trades ranging from $150.21 to $151.18. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.